Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs

Journal of Pharmacology and Experimental Therapeutics

Volumn 297, Issue 1, 2001, Pages 165-173

  Aoki, M ^a   Yamamoto, S ^a   Kobayashi, M ^a   Ohga, K ^a   Kanoh, H ^a   Miyata, K ^a   Honda, K ^a   Yamada, T ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROPHENYL) 1,7 DIETHYLPYRIDO[2,3 D]PYRIMIDIN 2(1H) ONE; CYCLIC AMP; PEROXIDASE; PHOSPHODIESTERASE IV INHIBITOR; PICLAMILAST; PREDNISOLONE; ROLIPRAM; SUPEROXIDE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHOSPASM; CELL INFILTRATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; EOSINOPHIL; EXTRAVASATION; GUINEA PIG; LEUKOCYTE ACTIVATION; LUNG EDEMA; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-ASTHMATIC AGENTS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL SPASM; BRONCHOCONSTRICTION; EOSINOPHILS; GUINEA PIGS; LEUKOTRIENE D4; LUNG; MALE; PHOSPHODIESTERASE INHIBITORS; PYRIDINES; PYRIMIDINONES; SUPEROXIDES;

EID: 0035082106     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro
2. Effect of a novel anti-inflammatory compound, YM976, on antigen-induced eosinophil infiltration into the lungs in rats, mice and ferrets
3. A novel phosphodiesterase type 4 inhibitor, YM976 (4-(3-chlorophenyl)-1,7-diethylpyridol[2,3-d]pyrimidin-2(1H)-one), with little emetogenic activity
4. Effects of verapamil on the response of the guinea-pig tracheal muscle to carbachol
5. Therapeutic strategies for allergic diseases
6. Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD)
7. The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity
8. Inhibition of PAF-induced expression of CD11b and shedding of L-selectin on human neutrophils and eosinophils by the type IV selective PDE inhibitor, rolipram
9. Anti-spasmogenic activity of isoenzyme-selective phosphodiesterase inhibitors in guinea-pig trachealis
10. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4
11. Effects of endogenous superoxide anion and nitric oxide on cholinergic constriction of normal and hyperreactive guinea pig airways
12. Potentiation of nonadrenergic noncholinergic relaxation of human isolated bronchus by selective inhibitors of phosphodiesterase isozymes
13. Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma
14. Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: Role in regulating proliferation and the biosynthesis of interleukin-2
15. Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF
16. Emetic, central nervous system, and pulmonary activities of rolipram in the dog
17. Effects of selective phosphodiesterase inhibitors on antigen-induced leukotriene release and leukotriene-dependent tracheal muscle contraction
18. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs
19. Interleukin-5 production by peripheral blood mononuclear cells of asthmatic patients is suppressed by T-440: Relation to phosphodiesterase inhibition
20. A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats
21. In vitro and in vivo effects of tachykinins on immune cell function in guinea pig airways
22. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells
23. Mechanisms of neutrophil and eosinophil accumulation in vivo
24. Rolipram inhibits airway microvascular leakage induced by platelet-activating factor, histamine and brady-kinin in guinea-pigs
25. Plasma exudation and asthma
26. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor
27. Biological effects of diesel exhaust particles (DEP). III. Pathogenesis of asthma like symptoms in mice
28. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMF-specific phosphodiesterase: Comparison with rolipram
29. The in vivo pharmacology of CP-80,633, a selective inhibitor of phosphodiesterase 4
30. Attenuation by phosphodiesterase inhibitors of lipopolysaccharide-induced thromboxane release and bronchoconstriction in rat lungs
31. Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus by isozyme-selective phosphodiesterase inhibitors
32. What is the role of the eosinophil?
33. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide